We have shown that prostate cancer (PCa)-associated NANOG is derived primarily from NANOGP8 and is enriched in CD44+ PCa stem/progenitor cells, and inversely correlates with differentiation factors androgen receptor (AR) and prostate-specific antigen (PSA) [3, 9]. This evidence concerns the gene NANOG and prostate carcinoma.